For best search results, use the search terms first and then apply the filters

The Award database is continually updated throughout the year. As a result, data for the given year is not complete until April of the following year. Annual Reports data is a snapshot of agency reported information for that year and hence might look different from the live data in the Awards Information charts.

  1. SBIR Phase I: Development of a novel graft to provide safe and reliable vascular access for hemodialysis patients

    SBC: Innavasc Medical, Inc.            Topic: MD

    This SBIR Phase I project will advance the development of a novel arteriovenous graft that will minimize injury and decrease the probability of serious complications for chronic hemodialysis patients. Hemodialysis is a life-sustaining therapy for patients suffering from kidney failure; it requires that blood be withdrawn and cycled through a dialysis machine that performs the function of the faile ...

    SBIR Phase I 2019 National Science Foundation
  2. SBIR Phase I: Transforming Complex Utility Transaction Management

    SBC: EnergyXchain, LLC            Topic: OT

    The broader impact/commercial potential of this Small Business Innovation Research (SBIR) project is empowering the 68 million U.S. natural gas consumers to know their transaction status in real time, have more and continual control of their transactions, settle transactions in increments less than the industry?s current monthly accounting cycle and enjoy an extremely high level of security. Their ...

    SBIR Phase I 2019 National Science Foundation
  3. SBIR Phase I: Engineering broad-spectrum disease resistance in soybean without fitness cost

    SBC: Upstream Biotechnology, Inc.            Topic: BT

    The broader impact/commercial potential of this Small Business Innovation Research (SBIR) project is to develop disease resistant soybean varieties that will reduce the substantial losses in agricultural production caused by plant diseases. Loss to disease can be as high as 40% globally and cost billions of dollars annually. In soybean alone, an estimated $3 billion dollars of production value is ...

    SBIR Phase I 2019 National Science Foundation
  4. SBIR Phase I: Non-Chromatographic Method for the Purification of Monoclonal Antibodies

    SBC: Isolere Bio, Inc            Topic: BT

    The broader impact/commercial potential of this Small Business Innovation Research (SBIR) project is to improve manufacturing technology for the purification of monoclonal antibodies, which are important therapeutics as well as valuable tools in research and diagnostics. Approximately four new antibody drugs are approved every year, and while they can have tremendous clinical outcomes and are some ...

    SBIR Phase I 2019 National Science Foundation
  5. SBIR Phase I: Progeny Analysis Of A Chimera-Free Hypoallergenic Peanut

    SBC: IngateyGen LLC            Topic: BT

    The broader impact/commercial potential of this Small Business Innovation Research (SBIR) Phase I project is to develop a hypo allergenic peanut (HAP) variety, which is expected to save human lives by preventing allergy-related deaths, reduce the incidence of peanut allergy, and increase security, comfort and peace of mind for those individuals sensitive to peanuts and their families, extended fam ...

    SBIR Phase I 2019 National Science Foundation
  6. SBIR Phase I: Chemically Resistant Membranes for Water Purification

    SBC: NALA Systems, Inc.            Topic: CT

    The broader impact/commercial potential of this Small Business Innovation Research (SBIR) project will provide new opportunities for purifying waters that cannot be economically treated using existing commercial membranes. Increased market growth to include recycle and re-use of contaminated water that is currently slated for disposal or long term environmentally risky storage will increase water ...

    SBIR Phase I 2019 National Science Foundation
  7. STTR Phase I: Tuned Miniaturized Point-Field Detectors as Contactless Current Sensor for Post-silicon Power Electronics

    SBC: Telli Technologies Inc            Topic: EW

    The broader impact/commercial potential of this project is to introduce a fully integrated current sensor with an order of magnitude performance improvement over state-of-the-art technologies. The developed technology will enable more reliable, efficient and compact power electronics systems. Power electronics is an integral part of today's power delivery systems such as renewable energy systems, ...

    STTR Phase I 2019 National Science Foundation
  8. SBIR Phase II: Online Game to Assess and Improve Behavioral Readiness and Social Emotional Skills for Students in Kindergarten and First Grades

    SBC: Personalized Learning Games Inc            Topic: EA

    This SBIR Phase II project aims to create and test a game-based intelligent tutoring system that both assesses and improves the behavioral readiness and social emotional skills of Kindergarten and 1st grade students. Research has shown that early intervention for children with social skill deficiencies is critical for success in the classroom and success in life. Children from vulnerable, underser ...

    SBIR Phase II 2019 National Science Foundation
  9. Effect of Surface Finish and Post-Processing on the Fatigue Life of Additively Manufacturing Parts

    SBC: Voxel Innovations, Inc.            Topic: N182126

    In response to the need for drastic surface finish improvement on additively manufactured metal components, Voxel Innovations Inc. has developed a novel manufacturing process termed: oscillatory pulsed electrochemical machining (O-PECM). O-PECM is a heat-free, stress-free, surface finishing technique capable of producing sub-200 nm Ra roughness. In O-PECM, a thin envelope of build material is prin ...

    SBIR Phase I 2019 Department of DefenseNavy
  10. Biphase Extended Release Tablet Formulation for Nerve Agent Pretreatment

    SBC: Zymeron Corporation            Topic: CBD181004

    Given the unforeseen/unanticipated use of nerve agents in the battlefield and on the homeland, military personnel can benefit from this oncedaily pretreatment. It may also be desirable to pretreat certain medical and emergency aid personnel following a known/suspected nerveagent attack. Also, a novel, improved PB extended release formulations can be commercialized for the treatment of myasthenia g ...

    SBIR Phase I 2019 Department of DefenseOffice for Chemical and Biological Defense

Agency Micro-sites

SBA logo
Department of Agriculture logo
Department of Commerce logo
Department of Defense logo
Department of Education logo
Department of Energy logo
Department of Health and Human Services logo
Department of Homeland Security logo
Department of Transportation logo
Environmental Protection Agency logo
National Aeronautics and Space Administration logo
National Science Foundation logo
US Flag An Official Website of the United States Government